Trials / Active Not Recruiting
Active Not RecruitingNCT05989035
Effects of MetAP2 Inhibition on Bioenergetics and Aging-associated Characteristics in Adipose Tissue in Healthy Participants
Effects of MetAP2 Inhibition on Bioenergetics and Aging-associated Characteristics in Adipose Tissue (BIO-AGE) in Healthy Participants
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 31 (actual)
- Sponsor
- AdventHealth Translational Research Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This study is being done to collect Adipose tissue from young and older individuals and gather data on the effect of methionine aminopeptidase protein (MetAP2) inhibition on that Adipose tissue in the laboratory.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Abdominal subcutaneous adipose tissue biopsy | Fatty tissue biopsy- Participant will be placed in a supine position with arms placed at side while abdominal skin is marked with a skin marker and cleansed with chlorhexidine. Afterwards, the abdominal fatty tissue biopsy will be performed. Collect fatty tissue from young and older individuals and gather data on the effect of methionine aminopeptidase protein (MetAP2) inhibition on that fatty tissue in the laboratory. |
Timeline
- Start date
- 2020-08-31
- Primary completion
- 2021-03-25
- Completion
- 2025-12-01
- First posted
- 2023-08-14
- Last updated
- 2025-03-13
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05989035. Inclusion in this directory is not an endorsement.